Tamiflu treatment may shorten flu isolation time, study suggests
NCT ID NCT04515446
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracks how long the flu virus stays in the upper airways of 18 hospitalized adults who are taking oseltamivir (Tamiflu). The goal is to see if antiviral treatment can safely shorten the time patients need to stay in isolation, freeing up hospital rooms during flu season. Researchers will also check if the flu type (A or B), vaccination status, or other health conditions affect how long the virus lingers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FLU are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Princesse Grace
Monaco, Municipality of Monaco, 98000, Monaco